Baker Brothers Life Sciences LP, Director, 10% Owner at IGM Biosciences, Inc. (IGMS), bought 840,525 shares at $5.76 ($5.4M) on 2023-12-13, disclosed to the SEC on 2023-12-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.76 | 9,649 | $56K | 1.0% |
| 2 | $5.76 | 9,649 | $56K | 1.0% |
| 3 | $5.76 | 769 | $4K | 0.1% |
| 4 | $5.99 | 5,679 | $34K | 0.6% |
| 5 | $5.99 | 71,219 | $427K | 7.9% |
| 6 | $5.99 | 71,219 |
| $427K |
| 7.9% |
| 7 | $6.50 | 145,749 | $947K | 17.6% |
| 8 | $6.50 | 11,621 | $76K | 1.4% |
| 9 | $6.50 | 11,621 | $76K | 1.4% |
| 10 | $6.50 | 145,749 | $947K | 17.6% |
| 11 | $6.36 | 15 | $95 | 0.0% |
| 12 | $6.36 | 185 | $1K | 0.0% |
| 13 | $6.37 | 52,528 | $335K | 6.2% |
| 14 | $6.37 | 52,528 | $335K | 6.2% |
| 15 | $6.37 | 4,188 | $27K | 0.5% |
| 16 | $6.60 | 214,025 | $1.4M | 26.2% |
| 17 | $6.60 | 17,066 | $113K | 2.1% |
| 18 | $6.60 | 17,066 | $113K | 2.1% |
| Total | $6.41 avg | 840,525 | $5.4M | 100% |
| Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |
| NLTX | BUY | 2023-08-17 | $2.9M | — | Filing → |